The Stockholm CREAtinine Measurements (SCREAM) project: fostering improvements in chronic kidney disease care

JJ Carrero, CG Elinder - Journal of internal medicine, 2022 - Wiley Online Library
Abstract SCREAM (Stockholm CREAtinine Measurements project) was initiated in 2010 in
collaboration with the healthcare provider of Stockholm County healthcare to quantify …

Acute renal injury events in diabetic patients treated with SGLT2 inhibitors: a comprehensive review with a special reference to RAAS blockers

AJ Scheen, P Delanaye - Diabetes & Metabolism, 2022 - Elsevier
Renin-angiotensin-aldosterone system (RAAS) blockers and sodium-glucose cotransporter
type 2 inhibitors (SGLT2is) are two pharmacological classes that proved a remarkable …

Chronic kidney disease and its health-related factors: a case-control study

M Ghelichi-Ghojogh, M Fararouei, M Seif, M Pakfetrat - BMC nephrology, 2022 - Springer
Background Chronic kidney disease (CKD) is a non-communicable disease that includes a
range of different physiological disorders that are associated with abnormal renal function …

Exposure to per-and polyfluoroalkyl substances and glycemic control in older US adults with type 2 diabetes mellitus

E Brosset, G Ngueta - Environmental Research, 2023 - Elsevier
Background Perfluoroalkyl substances (PFAS) have been associated with impaired glucose
homeostasis. We aimed to examine associations of serum concentrations of PFAS with poor …

[HTML][HTML] Acute kidney injury in diabetes mellitus: epidemiology, diagnostic and therapeutic concepts

Y Gui, Z Palanza, H Fu, D Zhou - FASEB journal: official publication …, 2023 - ncbi.nlm.nih.gov
Acute kidney injury (AKI) and diabetes mellitus (DM) are public health problems that cause a
high socioeconomic burden worldwide. In recent years, the landscape of AKI etiology has …

Far-red light-activated human islet-like designer cells enable sustained fine-tuned secretion of insulin for glucose control

G Yu, M Zhang, L Gao, Y Zhou, L Qiao, J Yin, Y Wang… - Molecular Therapy, 2022 - cell.com
Diabetes affects almost half a billion people, and all individuals with type 1 diabetes (T1D)
and a large portion of individuals with type 2 diabetes rely on self-administration of the …

Long-term visit-to-visit variability in hemoglobin A1c and kidney-related outcomes in persons with diabetes

Y Xu, S Dong, EL Fu, A Sjölander, ME Grams… - American Journal of …, 2023 - Elsevier
Rationale & Objective To characterize associations between long-term visit-to-visit variability
of hemoglobin A 1c (HbA 1c) and risk of adverse kidney outcomes in patients with diabetes …

Comparison of adverse kidney outcomes with empagliflozin and linagliptin use in patients with type 2 diabetic patients in a real-world setting

YT Lee, CN Hsu, CM Fu, SW Wang… - Frontiers in …, 2021 - frontiersin.org
Background: To compare the effects of empagliflozin and linagliptin use on kidney outcomes
of type 2 diabetes mellitus (T2DM) patients in a real-world setting. Methods: The study …

Adherence to a healthy sleep pattern and new-onset acute kidney injury

X Gan, P He, Z Ye, C Zhou, M Liu, S Yang, Y Zhang… - Sleep Health, 2023 - Elsevier
Objectives To investigate the prospective association of individual sleep characteristics and
a healthy sleep pattern with new-onset acute kidney injury in general population. Methods …

A Machine Learning–Based Predictive Model to Identify Patients Who Failed to Attend a Follow-up Visit for Diabetes Care After Recommendations From a National …

A Okada, Y Hashimoto, T Goto, S Yamaguchi… - Diabetes …, 2022 - Am Diabetes Assoc
OBJECTIVE Reportedly, two-thirds of the patients who were positive for diabetes during
screening failed to attend a follow-up visit for diabetes care in Japan. We aimed to develop a …